Back to CVE records
Critical 10.0HealthcarePublished Jun 24, 2022
CVE-2022-15183.2.2 IMPROPER LIMITATION OF A PATHNAME TO A RESTRICTED DIRECTORY ('PATH TRAVERSAL') CWE-22
Updated under an hour ago ()
Does this affect you?
It affects Illumina NextSeq 550Dx and 7 other products. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 1.63%, higher than 76% of scored CVEs.
Do this next
Start free and add your stack
Free account, 1 product
LRM contains a directory traversal vulnerability that can allow a malicious actor to upload outside the intended directory structure.
- CVSS
- 10.0 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- CWE-22
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 1.63% (percentile 76)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Apr 16, 2025
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
Illumina NextSeq 550Dx illumina:nextseq_550dx (from the name) | LRM Versions 1.3 to 3.1 | CNA record |
Illumina MiSeq Dx illumina:miseq_dx (from the name) | LRM Versions 1.3 to 3.1 | CNA record |
Illumina NextSeq 500 Instrument illumina:nextseq_500_instrument (from the name) | LRM Versions 1.3 to 3.1 | CNA record |
Illumina NextSeq 550 Instrument illumina:nextseq_550_instrument (from the name) | LRM Versions 1.3 to 3.1 | CNA record |
Illumina MiSeq Instrument illumina:miseq_instrument (from the name) | LRM Versions 1.3 to 3.1 | CNA record |
Illumina iSeq 100 Instrument illumina:iseq_100_instrument (from the name) | LRM Versions 1.3 to 3.1 | CNA record |
Illumina MiniSeq Instrument illumina:miniseq_instrument (from the name) | LRM Versions 1.3 to 3.1 | CNA record |
illumina local_run_manager illumina:local_run_manager | from 1.3 through 3.1 | NVD |
References
- https://www.cisa.gov/uscert/ics/advisories/icsa-22-153-02x-refsource-misc, third-party-advisory, us-government-resource
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.